SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001171843-20-006048
Filing Date
2020-08-21
Accepted
2020-08-21 16:45:07
Documents
3
Effectiveness Date
2020-08-21

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A defa14a_082120.htm DEFA14A 15009
2 GRAPHIC proxy_1.jpg GRAPHIC 105161
3 GRAPHIC proxy_2.jpg GRAPHIC 47934
  Complete submission text file 0001171843-20-006048.txt   227272
Mailing Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876
Business Address 20271 GOLDENROD LANE STE 2024 GERMANTOWN MD 20876 301-366-4841
Seneca Biopharma, Inc. (Filer) CIK: 0001357459 (see all company filings)

IRS No.: 522007292 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33672 | Film No.: 201123946
SIC: 2836 Biological Products, (No Diagnostic Substances)